The Non-Malignant Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO 2024 | The need for up-to-date and evidence-based data for the use of DLIs in SCD
Jaap-Jan Boelens, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the need for up-to-date and evidence-based data on the use of donor lymphocyte infusions (DLIs) in bone marrow transplantation for sickle cell disease (SCD). He emphasizes the need to move beyond expert opinions and study DLIs in clinical trial settings. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
